LoanCare has completed preparations to implement the Department of Veterans Affairs' new Partial Claim Program, which helps veterans facing financial hardship avoid foreclosure by offering a three-month trial payment plan. If veterans successfully complete the trial, LoanCare advances the overdue amount, reimbursed by the VA, to bring the loan current. This program, launching November 28, 2026, provides veterans with new payment relief options and helps LoanCare improve delinquency resolution and portfolio performance. Early adoption positions LoanCare as a leader in supporting veteran borrowers and meeting evolving agency requirements.
LoanCare's readiness for the VA Partial Claim Program offers context for financial sector activity. For readers following Financials, here is Pluang's market snapshot as of Sep 17, 2026 19:12 WIB: Of 74 priced US Financials stocks tradable on Pluang, 67 rose and 5 fell today. Notable movers include STM at USD 48.98 (+1.91%, 66 days typical hold time, 99% sell orders), Deutsche Bank AG at USD 39.08 (+1.88%, 79 days typical hold time, 100% buy orders), and BBVA at USD 28.60 (+1.78%, 80 days typical hold time, 100% buy orders).
Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...
ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...
Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...
eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...
Balchem Corporation reported strong Q3 2026 results with net sales of $290.7 million, up 8.6% year-over-year, and net earnings of $46.7 million, a 16% increase. Growth was driven by all three segments: Human Nutrition and Health, Animal Nutrition and...
